1 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Institut Guttmann: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation Allogeneic Wharton's jelly mesenchymal stem cells (WJ-MSCs) - Spinal Cord Injuries (SCI), Spinal Cord Injury | Phase 1 / Phase 2 | Not yet recruiting | Institut Guttmann | 10 | 2025-09-01 | 2025-05-25 |
| Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury WJ-MSC (XCEL-UMC-BETA), Placebo - Spinal Cord Injury Cervical | Phase 1 / Phase 2 | Completed | Banc de Sang i Teixits | 18 | 2021-10-13 | 2024-01-24 |
Spinal Cord Injuries (2) · Spinal Cord Diseases (1)
Spain (2)
2025 (1)